SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Vascular and Endovascular Surgery
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Petrik, P. V.
Right arrow Articles by Quinones-Baldrich, W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Petrik, P. V.
Right arrow Articles by Quinones-Baldrich, W.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Pentoxifylline Improves Skeletal Muscle Recovery After Acute Ischemic and Reperfusion Injury

Pavel V. Petrik

UCLA School of Medicine CHS 72-169, 10833 Le Conte Ave. Los Angeles, CA 90024

Bruce Braithwaite

UCLA School of Medicine CHS 72-169, 10833 Le Conte Ave. Los Angeles, CA 90024

Wesley S. Moore

UCLA School of Medicine CHS 72-169, 10833 Le Conte Ave. Los Angeles, CA 90024

Hugh A. Gelabert

UCLA School of Medicine CHS 72-169, 10833 Le Conte Ave. Los Angeles, CA 90024

William Quinones-Baldrich

UCLA School of Medicine CHS 72-169, 10833 Le Conte Ave. Los Angeles, CA 90024

Purpose: Skeletal muscle ischemia is associated with complex interactions involving neutrophils, erythrocytes, oxygen free radicals, and complement factors that lead to development of reperfusion injury on restoration of blood flow. Pentoxifylline is known to decrease neutrophil margination, improve erythrocyte passage through the capillary system, and possibly serve as an oxygen radical scavenger. The authors hypothesized that the addition of pentoxifylline to the reperfusate might improve muscle recovery after acute ischemic injury.

Methods: Twenty-four New Zealand White rabbits underwent vascular isolation of both hind limbs, leaving the external iliac and femoral arteries as sole inflow arteries for each respective limb. The animal was secured to an operating board such that each tibialis anterior muscle was attached to a force transducer, and muscle contractions after maximal tetanic stimulation were recorded on an oscilloscope at timed intervals. Acute occlusion was induced in the right hind limb by use of removable vascular clips and continued until < 15% of contralateral limb function was achieved. The animal was then (continued on next page) (Abstract continued) reperfused with saline "control " or pentoxifylline (50 mg/kg) "treated." Muscle function was recorded in each limb at 5, 30, 60, 90, and 120 minutes after reperfusion.

Results: A continual trend of muscle function improvement was noted in the pentoxi fylline-treated group, reaching statistical significance compared with controls after 30 minutes (16.8% of contralateral limb; P<0.04) and 120 minutes (36.7% of contralat eral limb ; P<0.04) of reperfusion. Control animals failed to demonstrate significant improvement in muscle function over the 2-hour reperfusion period.

Conclusion: Pentoxifylline improved muscle function recovery after acute ischemic injury in the rabbit hind limb model.

Vascular and Endovascular Surgery, Vol. 32, No. 1, 5-12 (1998)
DOI: 10.1177/153857449803200102


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement